Engineers Gate Manager LP Esperion Therapeutics, Inc. Transaction History

Engineers Gate Manager LP

$5.55 Billion
Q1 2025

A detailed history of Engineers Gate Manager LP transactions in Esperion Therapeutics, Inc. stock. As of the latest transaction made, Engineers Gate Manager LP holds 19,131 shares of ESPR stock, worth $28,887. This represents 0.0% of its overall portfolio holdings.

Number of Shares

19,131

Previous 53,373 64.16%

Holding current value

$28,887

Previous $117,000 76.92%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$1.44 - $2.34 $49,308 - $80,126	-34,242 Reduced 64.16%	19,131 $27,000
Q4 2024 Feb 14, 2025	BUY	$1.61 - $3.83 $56,322 - $133,984	34,983 Added 190.23%	53,373 $117,000
Q3 2024 Nov 14, 2024	BUY	$1.61 - $2.73 $29,607 - $50,204	18,390 New	18,390 $30,000
Q4 2023 Feb 14, 2024	BUY	$0.73 - $3.08 $3,314 - $13,986	4,541 Added 9.38%	52,932 $158,000
Q3 2023 Nov 14, 2023	SELL	$0.96 - $1.79 $23,423 - $43,674	-24,399 Reduced 33.52%	48,391 $47,000
Q2 2023 Aug 14, 2023	BUY	$1.2 - $1.76 $87,348 - $128,110	72,790 New	72,790 $101,000
Q3 2022 Nov 14, 2022	BUY	$5.45 - $8.13 $79,548 - $118,665	14,596 New	14,596 $98,000
Q1 2022 May 16, 2022	SELL	$3.34 - $5.56 $42,094 - $70,072	-12,603 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$4.81 - $11.92 $232,438 - $576,022	-48,324 Reduced 79.31%	12,603 $63,000
Q3 2021 Nov 15, 2021	BUY	$11.34 - $21.37 $262,532 - $494,736	23,151 Added 61.28%	60,927 $734,000
Q2 2021 Aug 16, 2021	BUY	$19.4 - $28.71 $94,361 - $139,645	4,864 Added 14.78%	37,776 $799,000
Q1 2021 May 17, 2021	BUY	$25.12 - $36.89 $4,998 - $7,341	199 Added 0.61%	32,912 $923,000
Q4 2020 Feb 16, 2021	BUY	$24.2 - $35.76 $791,654 - $1.17 Million	32,713 New	32,713 $851,000
Q3 2020 Nov 16, 2020	SELL	$31.18 - $52.71 $275,007 - $464,902	-8,820 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	$30.04 - $51.31 $264,952 - $452,554	8,820 New	8,820 $453,000
Q3 2019 Nov 14, 2019	SELL	$34.47 - $47.53 $289,513 - $399,204	-8,399 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$40.1 - $52.33 $336,799 - $439,519	8,399 New	8,399 $391,000

Others Institutions Holding ESPR

# of Institutions

201

Shares Held

119M

Call Options Held

171K

Put Options Held

679K

View Full List

About Esperion Therapeutics, Inc.

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $100M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

More about ESPR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.

Account

Engineers Gate Manager LP Esperion Therapeutics, Inc. Transaction History